Karen Von Graevenitz

Head Regulatory Affairs

A Pharmacist from University of Basel with over 30 years of experience in Pharma. Karen started her career at Roche in Basel (Switzerland) in Medical Marketing and seven years later, she moved into Global Drug Development Regulatory Affairs. During this period, she was involved and leading many meetings with all major Health Authorities, mainly in the cardiovascular & metabolic, CNS and breast cancer space. In 2014, Karen joined Novartis Oncology as a Sub-Region Head Oncology for AsiaPacific in Regulatory Affairs and in 2017, she became Head of New Product Planning Oncology for Asia, Middle East and Africa region. She has successfully managed major filings and approvals for NDAs and new indications. Karen joined Priothera on 1-April-2021.